3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
29
Neoplasms
10
Brain Neoplasms
6
Neoplasm Metastasis
3
Thyroid Neoplasms
2
Thyroid Cancer, Papillary
2
Skin Neoplasms
2
Multiple Myeloma
2
Hematologic Neoplasms
2
Glioma
2
Carcinoma, Non-Small-Cell Lung
2
Thyroid Carcinoma, Anaplastic
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Oligodendroglioma
1
Nonseminomatous germ cell tumor
1
Neurofibroma, Plexiform
1
Neurocytoma
1
Neuroblastoma
1
Lymphoma
1
Leukemia, Hairy Cell
1
Histiocytosis, Langerhans-Cell
1
Glioblastoma
1
Gastrointestinal Stromal Tumors
1
Ganglioneuroma
1
Ganglioglioma
1
Fever
1
Differentiated Thyroid Cancer (DTC)
1
Colorectal Neoplasms
1
Biliary Tract Neoplasms
1
Astrocytoma
1
Interventions
Fluorouracil
34
Cisplatin
34
Radiotherapy
30
Oxaliplatin
30
Paclitaxel
22
pembrolizumab
20
Irinotecan
20
Docetaxel
20
Leucovorin
19
Capecitabine
16
Cetuximab
11
Carboplatin
11
Bevacizumab
11
Radiation
10
Surgical Procedures, Operative
9
Trastuzumab
8
Panitumumab
6
Epirubicin
6
Neoadjuvant Therapy
5
Esophagectomy
4
Erlotinib Hydrochloride
4
Chemotherapy, Adjuvant
4
tisotumab vedotin
3
durvalumab
3
Sunitinib
3
Microarray Analysis
3
Immunohistochemistry
3
Gene Expression Profiling
3
Gemcitabine
3
Albumin-Bound Paclitaxel
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Esophageal Neoplasms
×
dabrafenib
×
Clear all
No trials found.